USPTO serial 79034419
CHONDROTISSUE
Reviewed by CopyMark Law Group
Reg. 3520741Status 404
- Filing date
- Status date
- Registration date
- Oct 21, 2008
- Examiner
- STEIN, JAMES W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CHONDROTISSUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
79108 Freiburg, DE
79108 Freiburg, DE
79108 Freiburg, DE
CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LAWRENCE J. CRAIN
LAWRENCE J. CRAIN GREER BURNS & CRAIN LTD.300 SOUTH WACKER DRIVE - STE 2500CHICAGO, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Polymer-based pharmaceutical preparations for use in tissue and organ transplantation, namely, regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers; biomedical polymer-based pharmaceutical preparations, namely, preparations for use in tissue and organ transplantation, namely regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers | SECTION 71 - CANCELLED | — |
| 010 | Medical devices in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; surgical implants primarily comprising artificial tissue, also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological surgical implants primarily comprising artificial tissue also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; health care products in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; products of tissue engineering, namely, surgical implants and modified surgical implants primarily comprising artificial material, also consisting of biological materials, all sold as a unit; tissue precursors, namely, surgical implants primarily comprising artificial material also consisting of molecules, namely, hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof produced in vitro for replacing and supporting the function of absent or injured body parts, all sold as a unit; artificial cartilage replacements and tissue replacements, namely, primarily artificial substitutes for bones, cartilage, ligaments, and tendons, also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological replacement and biological protection of mesenchymal tissue, namely, primarily artificial substitutes for bones, cartilage, ligaments and tendons also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit | SECTION 71 - CANCELLED | — |
| 042 | Research and development of pharmaceutical preparations and medicines; consultancy in the field of biomedicine | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioTissue Technologies GmbH
- Other trademarks owned by BioTissue Technologies GmbH
- Other trademarks owned by BioTissue Technologies GmbH
- Other trademarks owned by BioTissue AG
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named CHONDROTISSUE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Sep 28, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 21, 2016 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 28, 2016 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 28, 2016 | INPC | INVALIDATION PROCESSED | — |
| Jan 22, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 22, 2015 | C71T | CANCELLED SECTION 71 | — |
| Jan 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 4, 2010 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 30, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 30, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 21, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 21, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 22, 2008 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 7, 2008 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 7, 2008 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 5, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 16, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 30, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 27, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jun 27, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 27, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 27, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 26, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 26, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 26, 2008 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 26, 2007 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 22, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 21, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Dec 21, 2007 | LIEC | LEGAL INSTRUMENT EXAMINER (LIE) - CORRECTION | — |
| Nov 28, 2007 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Nov 28, 2007 | ALIE | ASSIGNED TO LIE | — |
| Oct 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 19, 2007 | PAPER RECEIVED | — | |
| Jul 12, 2007 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 3, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 19, 2007 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 18, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 18, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 18, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 17, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 1, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 1, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |